4.5 Article

Lymphoid Malignancies in US Asians: Incidence Rate Differences by Birthplace and Acculturation

期刊

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
卷 20, 期 6, 页码 1064-1077

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-11-0038

关键词

-

资金

  1. National Cancer Institute [HHSN261201000036C]
  2. SEER Program [N01-PC-35136, N01-PC-35139, N01-PC-54404]
  3. Centers for Disease Control and Prevention [1U58DP00807-01]
  4. NIEHS [R01-ES015552]
  5. NCI [R01-CA121052]

向作者/读者索取更多资源

Background: Malignancies of the lymphoid cells, including non-Hodgkin lymphomas (NHL), HL, and multiple myeloma, occur at much lower rates in Asians than other racial/ethnic groups in the United States. It remains unclear whether these deficits are explained by genetic or environmental factors. To better understand environmental contributions, we examined incidence patterns of lymphoid malignancies among populations characterized by ethnicity, birthplace, and residential neighborhood socioeconomic status (SES) and ethnic enclave status. Methods: We obtained data about all Asian patients diagnosed with lymphoid malignancies between 1988 and 2004 from the California Cancer Registry and neighborhood characteristics from U.S. Census data. Results: Although incidence rates of most lymphoid malignancies were lower among Asian than white populations, only follicular lymphoma (FL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), and nodular sclerosis (NS) HL rates were statistically significantly lower among foreign-born than U. S.-born Asians with incidence rate ratios ranging from 0.34 to 0.87. Rates of CLL/SLL and NS HL were also lower among Asian women living in ethnic enclaves or lower SES neighborhoods than those living elsewhere. Conclusions: These observations support strong roles of environmental factors in the causation of FL, CLL/SLL, and NS HL. Impact: Studying specific lymphoid malignancies in U.S. Asians may provide valuable insight toward understanding their environmental causes. Cancer Epidemiol Biomarkers Prev; 20(6); 1064-77. (C)2011 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据